David Domzalski

2021

In 2021, David Domzalski earned a total compensation of $4.9M as President and Chief Executive Officer at VYNE Therapeutics, a 69% increase compared to previous year.

Compensation breakdown

Bonus$242,910
Option Awards$2,141,994
Salary$637,560
Stock Awards$1,818,861
Other$11,600
Total$4,852,925

Domzalski received $2.1M in option awards, accounting for 44% of the total pay in 2021.

Domzalski also received $242.9K in bonus, $637.6K in salary, $1.8M in stock awards and $11.6K in other compensation.

Rankings

In 2021, David Domzalski's compensation ranked 2,718th out of 12,406 executives tracked by ExecPay. In other words, Domzalski earned more than 78.1% of executives.

ClassificationRankingPercentile
All
2,718
out of 12,406
78th
Division
Manufacturing
1,073
out of 5,492
81st
Major group
Chemicals And Allied Products
421
out of 2,368
82nd
Industry group
Drugs
367
out of 2,089
82nd
Industry
Pharmaceutical Preparations
243
out of 1,536
84th
Source: SEC filing on June 17, 2022.

Domzalski's colleagues

We found two more compensation records of executives who worked with David Domzalski at VYNE Therapeutics in 2021.

2021

Mutya Harsch

VYNE Therapeutics

Chief Legal Officer

2021

Iain Stuart

VYNE Therapeutics

Chief Scientific Officer

News

You may also like